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1INTRODUCTION Introduction
The following FCAA report provides an update on United States (U.S.) private,
institutional grantmaking commitments in 2001 and 2002 focused on HIV/AIDS in the
U.S. and internationally.1 2 This report summarizes the most current data on HIV-
related grant commitments from all sectors of U.S. philanthropy, including private,
family, and community foundations, public charities, and corporate grantmaking
programs.3 4
FCAA has a commitment to accurately documenting and analyzing the parameters
and trends in U.S.-based HIV/AIDS-related grantmaking as part of its mission to fully
mobilize philanthropic leadership and the grantmaker response to HIV/AIDS.  As a
result of growing demand by funders, public policymakers, and others, FCAA has
significantly enhanced its work in this critical research area.  During the past two
years alone, FCAA has published and widely distributed its June 2002 "Report on
AIDS Grantmaking by U.S. Philanthropy"5 and its January 2003 research binder
entitled “HIV/AIDS Philanthropy: History and Current Parameters 1981-2000”.6
This report not only updates but improves upon this previous FCAA research in
valuable ways:
• In this report, FCAA has expanded its “Top U.S.-Based HIV/AIDS Grantmaker
List” to include the Top 50 such U.S. grantmakers (from the Top 25);
• FCAA has now produced information for two years’ worth of U.S.-based
grantmaking in this report: 2001 and 2002 (though the 2002 data is slightly
less comprehensive and final than the 2001 data reported here) whereas our
2002 report covered one year of data – for year 2000;
• FCAA has expanded reporting on the corporate philanthropic response to
HIV/AIDS in this publication, which can be an often under-researched and
somewhat overlooked element of HIV/AIDS funding and leadership;
• And finally, FCAA has added valuable information about the regional and
international distribution of private, U.S.-based HIV/AIDS grants.
As difficult as quantifying and analyzing private grant support for any particular issue
area can be, FCAA regards this work as critical. Accurate information is especially
important now, as global HIV/AIDS resource needs expand dramatically and as the
recent economic downturn potentially restricts necessary growth in HIV/AIDS
grantmaking, government funding and individual giving.
FCAA has created this report as a practical tool for grantmakers in assessing,
developing and sustaining their HIV/AIDS efforts.  This report is also useful for those
outside of philanthropy to better understand and work with HIV/AIDS grantmakers in
enhancing all types of resources flowing to HIV/AIDS initiatives. As always, our
central aim in creating this report is to assist in mobilizing a broader, more diverse
and increasingly strategic philanthropic response to this pandemic.
2OVERVIEWOverview
The HIV/AIDS pandemic generates a regular and horrifying stream of statistics that
indicate the scale of global human suffering.  Overall, as of 2003, it is estimated that HIV
has infected 65 to 70 million people around the world.  More than 40 million people are
living with HIV/AIDS, and HIV continues to spread at an estimated rate of nearly 14,000
people per day.7
This FCAA report provides another set of statistics: figures related to the level and nature
of U.S. private grantmaking commitments directed to HIV/AIDS from hundreds of
funders.
Numbers about costs and resources are often quoted in HIV/AIDS reports – to describe
the economic costs of HIV/AIDS, the inadequate level of funds available to address the
pandemic in the United States and globally, and the gap between current funding versus
needed resources.
To address the myriad needs created by this disease and to end the pandemic as quickly
as possible, much more funding is needed from all sources, including governments,
multilateral agencies, grantmakers, and individuals.  For example:
• In Fiscal Year 2002, the United States government committed a total of $14.7
billion to combat HIV/AIDS, $7 billion of which was discretionary funding. 8 9
Advocates and public health experts have documented many additional resource
needs for HIV/AIDS prevention, care, research, and a fair share of U.S. support for
international HIV/AIDS efforts beyond this level.  These same organizations and
individuals have expressed strong concerns about the prospect of achieving these
additional levels of funding, given level funding requests from the current U.S.
administration for HIV/AIDS efforts through FY 2005.10 11
• In 2002, UNAIDS estimates that that HIV/AIDS spending for all low and middle-
income countries was less than $3.9 billion.12 13  To successfully combat HIV/AIDS
in all low and middle-income countries, UNAIDS estimates that at least $10 billion
per year will be needed by 2005.14  In sub-Saharan Africa, UNAIDS states that
HIV/AIDS spending was only $950 million in 2002, and that annual resource
needs for basic HIV/AIDS prevention and treatment in Africa are expected to grow
to $5 billion by 2005, with another $1 billion needed to provide antiretroviral
medications. 15
Measuring the gap between funding needs and funding expenditures requires reliable
data and rigorous analysis.16  In this report, FCAA contributes data from the field of U.S.-
based institutional philanthropy.  The data in this report reflect FCAA’s most current
estimates of all resources committed in 2001 and 2002 from U.S.-based grantmakers’
HIV/AIDS programs both in the U.S. and globally.
3FINDINGS FCAA Findings
In researching this report, FCAA found the following:
• In 2001, overall HIV/AIDS funding commitments from U.S.-based grantmakers totaled more
than $500 million. FCAA identified a total of 3,755 HIV/AIDS-related grants representing an
unduplicated total of $500,716,140 of funding committed in 2001.
• This 2001 figure represents an unprecedented, record high level of private HIV/AIDS
grantmaking by U.S.-based funders.  It is further indication of the critical role U.S. philanthropy
continues to play in the expanding response to HIV/AIDS, especially at the global level.
• In 2002, overall HIV/AIDS funding commitments from U.S.-based grantmakers totaled at
least $291 million.  FCAA identified a total of 3,652 HIV/AIDS-related grants representing an
unduplicated total of $291,914,539 of funding committed in 2002.
• The 2002 figure represents a significant decline from the 2001 level of grantmaking.  Though
very troublesome, the significance of this drop is somewhat unclear.  For example, overall
funding amounts actually paid out in 2002 from multiyear grants committed in 2000 and 2001
probably resulted in a steady increase in distributed HIV/AIDS grant dollars in 2002.  Also, the
decline in HIV/AIDS commitments was caused by the activities of four major funders rather
than a widespread decline in HIV/AIDS involvement across the sector.  Very preliminary
information on funding for 2003 suggests that this 2002 decline may not represent any
downward trend in HIV/AIDS grantmaking overall.
• The distribution of funding commitments was concentrated among large HIV/AIDS
grantmakers. Approximately 44% of the dollar total for 2001 and 2002 was committed by the
Bill & Melinda Gates Foundation.  The largest ten U.S. HIV/AIDS grantmakers accounted for a
full 73% of all calculated HIV/AIDS grantmaking in this same two-year period. The top 50 U.S.
HIV/AIDS grantmakers accounted for 95% of all calculated grant commitments in this two-year
period.
• U.S.-based philanthropic investments in HIV/AIDS efforts were extraordinarily diverse
geographically and programmatically.  Hundreds of U.S. grantmakers provided funding,
independently and in collaboration, to address HIV/AIDS. Their average grants ranged in size
from less than $2,000 to more than $40 million per grant.  U.S. grantmakers described
HIV/AIDS both as a distinct funding priority and also as one part of other funding areas, such as
reproductive health or community development.  Grants were directed across to the United
States and the world, and were focused upon a wide array of areas from HIV/AIDS treatment,
prevention, research, public policy work to various aspects of economic development and
social and economic justice.
• There is capacity among U.S. grantmakers to continue increases in HIV/AIDS grant
commitments.  Among the 50 largest U.S. HIV/AIDS grantmakers, only 25 committed 10% or
more of their total grant dollars to efforts against HIV/AIDS in 2001.  Many grantmakers are
increasingly seeing the ways in which HIV/AIDS issues are intertwined with their traditional
areas of funding, and thus realizing the benefits of and need for integration of HIV/AIDS
funding into these other portfolios. Once the current economic and resulting philanthropic
downturn reverses, more resources could be made available for grantmaking in this area.
4TOTALSTotal U.S. HIV/AIDS-Related Grantmaking in 2001 and 2002
• In 2001, HIV/AIDS-related funding commitments by U.S. grantmakers reached an
estimated unduplicated total of $500.7 million.17  In its 2001 calculations, FCAA
identified an additional $188 million in grant commitments over and above the FCAA
estimated total of $312 million for 2000.18 19 This represents an impressive 60% increase
from 2000 levels of HIV/AIDS funding by U.S.-based grantmakers.
• This $500.7 million represents an unprecedented grant amount allocated to
HIV/AIDS.  It is further indication of the critical role U.S. philanthropy continues to play
in the expanding response to HIV/AIDS, especially at the global level.  In light of
FCAA’s campaign to remobilize, diversify and deepen the philanthropic response to
HIV/AIDS, FCAA is encouraged by this turn of events.










































• In 2002, HIV/AIDS-related funding commitments by U.S. grantmakers reached an
estimated unduplicated total of $291.9 million.20  For 2002, FCAA identified $210
million less in total HIV/AIDS grantmaking commitments from levels calculated for
















5TOTALSTotal U.S. HIV/AIDS-Related Grantmaking in 2001 and 2002
• Though troublesome, the significance of this drop is somewhat unclear.  For example,
overall funding amounts actually paid out in 2002 from multiyear grants committed in
2000 and 2001 probably resulted in a steady increase in distributed HIV/AIDS grant
dollars in 2002.
• The decrease in reported HIV/AIDS grantmaking commitments from 2001 to 2002 was
also mainly due to a combined reported decrease of $226 million in HIV/AIDS
grantmaking commitments from four U.S. grantmakers - the Bill & Melinda Gates
Foundation, The David and Lucile Packard Foundation, The William and Flora Hewlett
Foundation, and the John D. and Catherine T. MacArthur Foundation.  This decrease
from 2001 to 2002 does not represent a widespread decline in HIV/AIDS grantmaking
by the hundreds of other funders making HIV/AIDS grants.
• Excluding these four grantmakers, a net increase would be seen from 2001 to 2002 in
total HIV/AIDS grantmaking.  This net increase by all other HIV/AIDS grantmakers from
year 2001 to year 2002 is itself somewhat reassuring, given the general 2001-2002
economic downturn in the U.S. and resulting stagnation in overall U.S. grantmaking
from 2001 to 2002.22
• Additionally, very preliminary information on funding for 2003 suggests that this 2002
decline may not represent any downward trend in HIV/AIDS grantmaking overall.
• There is capacity among U.S. grantmakers to continue increases in HIV/AIDS grant
commitments.  Among the 50 largest U.S. HIV/AIDS grantmakers, only 25 committed
10% or more of their total grant dollars to efforts against HIV/AIDS in 2001.  Many
grantmakers are increasingly seeing the ways in which HIV/AIDS issues are intertwined
with their traditional areas of funding, and thus realizing the benefits of and need for
integration of HIV/AIDS funding into these other portfolios. Once the current economic
and resulting philanthropic downturn reverses, more resources could be made available
for grantmaking in this area.
6DISTRIBUTIONDistribution of U.S. HIV/AIDS-Related Grantmaking in 2001 and 2002
• HIV/AIDS funding commitments by U.S.-based grantmakers remain heavily
concentrated among a small number of HIV/AIDS funders.  Funding commitments from
the largest U.S. HIV/AIDS grantmaker (The Bill & Melinda Gates Foundation), for
example, accounted for 44% of all combined HIV/AIDS grantmaking commitments in
2001 and 2002.  The top 50 U.S. HIV/AIDS grantmakers accounted for 95% of this
HIV/AIDS grantmaking commitment total for both years.





















































Largest U.S. HIV/AIDS Grantmaker
(Bill & Melinda Gates Foundation)
$356,000,000 44%
  Next 9 HIV/AIDS Grantmakers $232,116,852 29%
Top 10 HIV/AIDS Grantmakers $588,116,852 73%
  Next 15 HIV/AIDS Grantmakers $123,011,861 15%
Top 25 HIV/AIDS Grantmakers $711,128,713 88%
  Next 25 HIV/AIDS Grantmakers $55,568,528 7%
Top 50 HIV/AIDS Grantmakers $766,697,241 95%
  Next 50 HIV/AIDS Grantmakers $24,165,836 3%
Top 100 HIV/AIDS Grantmakers $790,863,077 98%
7TOP 50 GRANTMAKERSTop 50 U.S. HIV/AIDS Grantmakers in 2001









1 Gates Foundation, Bill & Melinda (WA) 267,000,000 17 
2 Packard Foundation, The David and Lucile (CA) 35,685,050 31 
3 Kaiser Family Foundation, The Henry J. (CA) 16,254,945 37 
4 Ford Foundation (NY) 15,500,000 71 
5 Hewlett Foundation, The William and Flora (CA) 14,775,000 10 
6 Bristol-Myers Squibb Foundation (NY) 14,500,000 39 
7 Merck Company Foundation, The (NJ) 11,400,000 1 
8 Elizabeth Glaser Pediatric AIDS Foundation (CA) 9,195,972 160 
9 United Nations Foundation (DC) 6,771,968 10 
10 International Fund for Health & Family Planning (NY) 6,433,000 2 
11 Abbott Laboratories Fund (IL) 6,200,000 1 
12 Broadway Cares/Equity Fights AIDS (NY) 6,068,265 448 
13 Open Society Institute / Soros Foundations (NY) 5,469,476 375 
14 Rockefeller Foundation, The (NY) 5,342,674 31 
15 MacArthur Foundation, The John D. and Catherine T. (IL) 5,313,000 9 
16 Starr Foundation, The (NY) 5,225,000 3 
17 California Endowment, The (CA) 4,771,636 22 
18 amfAR (NY) 4,500,000 141 
19 M⋅A⋅C AIDS Fund (NY) 2,946,505 75 
20 Levi Strauss Foundation (CA) 2,720,245 75 
21 Tides Foundation (CA) 2,715,000 75 
22 Robert Wood Johnson Foundation, The (NJ) 2,554,237 19 
23 Association François-Xavier Bagnoud (MA) 2,352,020 10 
24 New York Community Trust, The (NY) 2,300,500 37 
25 Irene Diamond Fund (NY) 2,105,683 7 
26 National AIDS Fund (DC) 2,090,263 453 
27 Public Welfare Foundation (DC) 1,867,000 26 
28 Robin Hood Foundation (NY) 1,829,500 9 
29 Altria Group, Inc. (NY) 1,800,000 90 
30 Carnegie Corporation of New York (NY) 1,620,682 2 
31 Pfizer Foundation, The (NY) 1,550,000 6 
32 Atlantic Philanthropies, The (NY) 1,450,000 3 
33 Elton John AIDS Foundation (CA) 1,299,912 378 
34 McCormick Tribune Foundation, Robert R. (IL) 1,294,000 18 
35 Gill Foundation (CO) 1,273,000 78 
36 Henry van Ameringen Foundation (NY) 1,139,000 38 
37 Rockefeller Brothers Fund (NY) 959,000 6 
38 Prudential Foundation, The (NJ) 885,000 18 
39 Burroughs Wellcome Fund (NC) 750,000 1 
40 Comer Foundation, The (IL) 730,000 18 
41 Tisch Foundation Inc. (NY) 710,000 2 
42 California Wellness Foundation, The (CA) 707,400 11 
43 Abell Foundation, The (MD) 655,000 1 
44 Firelight Foundation, The (CA) 646,499 48 
45 Houston Endowment Inc. (TX) 615,000 7 
46 San Francisco Foundation, The (CA) 611,600 19 
47 Donner Foundation, Inc., The William H. (NY) 605,000 4 
48 Meyer Foundation (DC) 570,000 4 
49 Wells Fargo Foundation (CA) 532,000 22 
50 DIFFA (NY) 524,766 46 
         Total 2001 HIV/AIDS Grantmaking from Top 50 $ 474,814,798 3,014
         TOTAL 2001 U.S. HIV/AIDS GRANTMAKING $ 500,716,140 3,755
8TOP 50 GRANTMAKERSTop 50 U.S. HIV/AIDS Grantmakers in 2002








1 Gates Foundation, Bill & Melinda (WA) 89,000,000 24 
2 Bristol-Myers Squibb Foundation (NY) 16,900,000 47 
3 Kaiser Family Foundation, The Henry J. (CA) 16,159,350 29 
4 Ford Foundation (NY) 14,000,000 78 
5 Rockefeller Foundation, The (NY) 12,956,589 37 
6 United Nations Foundation (DC) 12,326,389 13 
7 Elizabeth Glaser Pediatric AIDS Foundation (CA) 11,780,831 170 
8 Merck Company Foundation, The (NJ) 11,400,000 1 
9 Open Society Institute / Soros Foundations (NY) 7,828,715 400 
10 Robert Wood Johnson Foundation, The (NJ) 7,825,580 64 
11 Abbott Laboratories Fund (IL) 6,950,000 1 
12 M⋅A⋅C AIDS Fund (NY) 5,607,152 160 
13 Starr Foundation, The (NY) 5,475,000 8 
14 Kellogg Foundation, W. K. (MI) 5,448,000 5 
15 Broadway Cares/Equity Fights AIDS (NY) 5,421,676 412 
16 Doris Duke Charitable Foundation (NY) 4,936,500 7 
17 Tides Foundation (CA) 4,480,400 125 
18 Hewlett Foundation, The William and Flora (CA) 4,300,000 6 
19 amfAR (NY) 3,600,000 145 
20 Packard Foundation, The David and Lucile (CA) 2,868,084 11 
21 Levi Strauss Foundation (CA) 2,600,000 69 
22 Pfizer Foundation, The (NY) 2,500,000 17 
23 California Endowment, The (CA) 2,471,154 24 
24 Irene Diamond Fund (NY) 2,150,000 5 
25 Atlantic Philanthropies, The (NY) 2,139,308 2 
26 Elton John AIDS Foundation (CA) 2,139,308 429 
27 National AIDS Fund (DC) 2,127,500 477 
28 Association François-Xavier Bagnoud (MA) 2,014,300 12 
29 Robin Hood Foundation (NY) 1,974,000 9 
30 Altria Group, Inc. (NY) 1,800,000 90 
31 Public Welfare Foundation (DC) 1,480,000 31 
32 Mott Foundation, Charles Stewart (MI) 1,300,000 6 
33 Pew Charitable Trusts, The (PA) 1,189,000 12 
34 Gill Foundation (CO) 1,074,900 76 
35 Carnegie Corporation of New York (NY) 1,005,000 2 
36 California Wellness Foundation, The (CA) 967,000 15 
37 Henry van Ameringen Foundation (NY) 896,500 37 
38 Meadows Foundation, Inc., The (TX) 767,900 5 
39 New York Community Trust, The (NY) 757,500 12 
40 Houston Endowment Inc. (TX) 710,000 6 
41 San Francisco Foundation, The (CA) 707,000 24 
42 Burroughs Wellcome Fund (NC) 603,000 3 
43 Duke Endowment, The (NC) 594,570 6 
44 DIFFA (NY) 590,882 41 
45 Overbrook Foundation, The (NY) 560,000 9 
46 Dade Community Foundation (FL) 553,000 25 
47 American Jewish World Service (NY) 545,131 26
48 Rockefeller Brothers Fund (NY) 540,000 8
49 Cafritz Foundation, The Morris & Gwendolyn (DC) 525,000 7
50 AT&T Foundation (NY) 447,000 8
         Total 2002 HIV/AIDS Grantmaking from Top 50 $280,993,219 3236
         TOTAL 2002 U.S. HIV/AIDS GRANTMAKING $ 291,914,539 3652
9INCREASES AND DECREASESIncreases and Decreases in HIV/AIDS Grantmaking
• While the overall amount of grant commitments in 2002 was down, several U.S.-based
grantmakers reported significant increases in their HIV/AIDS-related funding
commitments. 23  In total, FCAA identified 18 U.S. HIV/AIDS grantmakers who increased
their HIV/AIDS funding allocations by 50% or more from 2001 to 2002.
Select U.S. Grantmakers with Net Increases in HIV/AIDS Grantmaking 2001- 2002
Net Increase in Grant Commitments
 Kellogg Foundation, W. K. (MI) 2624.00%
 Doris Duke Charitable Foundation (NY) 867.94%
 Atlantic Philanthropies, The (NY) 712.47%
 Cafritz Foundation, The Morris & Gwendolyn (DC) 556.25%
 Meadows Foundation, Inc., The (TX) 386.01%
 Mott Foundation, Charles Stewart (MI) 225.00%
 Robert Wood Johnson Foundation, The (NJ) 206.38%
 Citigroup Foundation (NY) 173.33%
 Rockefeller Foundation, The (NY) 142.51%
 American Jewish World Service (NY) 132.05%
 Dade Community Foundation (FL) 123.21%
 M⋅A⋅C AIDS Fund (NY) 90.30%
 California Community Foundation (CA) 89.01%
 United Nations Foundation (DC) 82.02%
 Tides Foundation (CA) 65.02%
 Elton John AIDS Foundation (CA) 64.57%
 Pfizer Foundation, The (NY) 61.29%
 Duke Endowment, The (NC) 54.13%
• Several U.S. grantmakers reported net decreases in HIV/AIDS-related grantmaking
commitments from 2001 to 2002.  In total, FCAA identified 14 major U.S. HIV/AIDS
grantmakers reporting decreased grantmaking from 2001 to 2002 by 50% or more.
Select U.S. Grantmakers with Net Decreases in HIV/AIDS Grantmaking 2001-2002
Net Decrease in Grant Commitments
 Gap Foundation, The (CA) -98.44%
 Abell Foundation, The (MD) -94.66%
 MacArthur Foundation, The John D. and Catherine T. (IL) -92.94%
 Ahmanson Foundation (CA) -92.06%
 Packard Foundation, The David and Lucile (CA) -91.96%
 Weingart Foundation (CA) -79.83%
 AT&T Foundation (NY) -62.50%
 Meyer Foundation (DC) -76.32%
 Hewlett Foundation, The William and Flora (CA) -70.90%
 New York Community Trust, The (NY) -67.07%
 Donner Foundation, Inc., The William H. (NY) -66.94%
 Gates Foundation, Bill & Melinda (WA) -66.67%
 Coca-Cola and Coca-Cola Africa Foundations (GA) -61.43%
 Federated Department Stores Foundation (OH) -58.58%
10
LARGESTThe Largest U.S. HIV/AIDS Grantmaker
• The U.S. grantmaker with the largest HIV/AIDS portfolio, the Bill & Melinda Gates
Foundation, continued to award several multi-million dollar grants in 2001 and 2002,
and remained the single largest private U.S. HIV/AIDS grantmaker in both of these years.
• In 2000, the Bill & Melinda Gates Foundation made several large HIV/AIDS funding
commitments, including a five-year $50 million grant to the African Comprehensive
HIV/AIDS Partnership and a five-year $50 million grant to Save the Children.
• In 2001, the Gates Foundation made several more of these awards, including a five-year
$100 million grant to the International AIDS Vaccine Initiative and a multi-year $100
million grant to the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
• In 2002, the Gates Foundation did not provide this same level of new commitments, but
the accumulated multiyear grants resulted in a steady increase in funding payouts for
HIV/AIDS in 2000, 2001, and 2002.24



































• Looking forward to 2003, preliminary data indicate that the Bill & Melinda Gates
Foundation have continued an extraordinary investment in global efforts against
HIV/AIDS.  In 2003, the Gates Foundation has made several large HIV/AIDS
commitments, including a multi-year grant of $60 million to the International Partnership
for Microbicides for international microbicide development, a multi-year $30 million
grant to the University of Washington Foundation for research on antiviral treatment as a
potential way to prevent sexual transmission of HIV, and the first $67.5 million
installment of a $200 million pledge by the Foundation to address HIV/AIDS in India.
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SMALL AND REGIONALSmall and Regional U.S. HIV/AIDS Grantmakers
• U.S. grantmakers offering smaller grants in the United States and internationally
maintained a steady effort, offering funding to often innovative grassroots HIV/AIDS
programs.
Selected U.S. Grantmakers Offering Small Grants in 2001 and 2002





Broadway Cares/Equity Fights AIDS (NY) 6,068,265 5,421,676
National AIDS Fund (DC) 2,090,263 2,127,500
Elton John AIDS Foundation (CA) 1,299,912 2,139,308
Gill Foundation (CO) 1,273,000 1,074,900
DIFFA (NY) 524,766 590,882
Firelight Foundation, The (CA) 646,499 446,301
John M. Lloyd Foundation, The (CA) 400,500 445,400
American Express Foundation (NY) 183,000 234,300
Ms. Foundation for Women (NY) 180,000 120,000
Geffen Foundation, The David (CA) 84,800 104,000
California HealthCare Foundation (CA) 55,000 68,000
Total $12,806,005 $12,772,267
• Several regionally-focused U.S. grantmakers were major HIV/AIDS grantmakers in 2001
and 2002.25
Regionally-Focused U.S. Grantmakers 2001-2002





California Endowment, The (CA) 4,771,636 2,471,154
Robin Hood Foundation (NY) 1,829,500 1,974,000
New York Community Trust, The (NY) 2,300,500 757,500
California Wellness Foundation, The (CA) 707,400 967,000
Houston Endowment Inc. (TX) 615,000 710,000
San Francisco Foundation, The (CA) 611,600 707,000
Prudential Foundation, The (NJ) 885,000 N/A
Dade Community Foundation  (FL) 247,748 553,000
Marin Community Foundation (CA) 351,750 447,000
Meyer Foundation (DC) 570,000 135,000
Abell Foundation, The (MD) 655,000 35,000
Boston Foundation, The (MA) 283,600 320,000
Wells Fargo Foundation (CA) 532,000 N/A
New York Foundation (NY) 215,000 265,000
Philadelphia Foundation, The (PA) 197,500 281,500
Total $14,773,234 $9,623,154
12
CORPORATE RESPONSECorporate Response to HIV/AIDS
• Despite the challenging economic climate on the last few years, corporations showed
ongoing, and in some cases, growing commitment in the HIV/AIDS arena, especially in
the international arena.  In 2001 and 2002, at least eight U.S. corporations were major
HIV/AIDS grantmakers, awarding more than $600,000 in HIV/AIDS-related grants in
each year.26 27
U.S. Corporate Grantmakers with the Largest HIV/AIDS Grantmaking 2001-2002





Bristol-Myers Squibb Foundation (NY) 14,500,000 16,900,000
Merck Company Foundation, The (NJ) 11,400,000 11,400,000
Abbott Laboratories Fund (IL) 6,200,000 6,950,000
M⋅A⋅C AIDS Fund (NY) 2,946,505 5,607,152
Levi Strauss Foundation (CA) 2,720,245 2,600,000
Pfizer Foundation, The (NY) 1,550,000 2,500,000
Altria Group, Inc. (NY) 1,800,000 1,800,000
Burroughs Wellcome Fund (NC) 750,000 603,000
• More than fifteen additional U.S. corporations made HIV/AIDS grants totaling $100,000
or more in 2001 and 2002.
U.S. Corporate Grantmakers with Significant HIV/AIDS Grantmaking 2001-2002





Prudential Foundation, The (NJ) 885,000 N/A
Federated Department Stores Foundation (OH) 441,858 183,000
Wells Fargo Foundation (CA) 532,000 N/A
Coca Cola / Coca Cola Africa Foundations (GA) 350,000 135,000
SBC Foundation (TX) 435,000 N/A
American Express Foundation (NY) 183,000 234,300
MetLife Foundation (NY) 200,000 200,000
Citigroup Foundation (NY) 105,000 287,000
Gap Foundation, The (CA) 320,000 5,000
Fannie Mae Foundation (DC) 181,100 110,000
Alcoa Foundation (PA) 196,323 10,000
Vivendi Universal Foundation, Inc. (NY) 185,000 N/A
J.P. Morgan Chase Foundation (NY) 168,500 N/A
Northwestern Mutual Foundation (WI) 150,000 N/A
Avon Foundation (NY) 100,000 N/A
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CORPORATE RESPONSECorporate Response to HIV/AIDS
• Beyond direct financial grants from either corporate foundations or giving programs, the
corporate sector also contributed to HIV/AIDS through various forms of in-kind
donations.  In-kind donations from companies provided added resources to the fight
against AIDS, such as resources in communications and marketing, logistics and
distribution, human resource and application of information technology.
Examples of U.S. Companies Making In-Kind Contributions to Address HIV/AIDS28
In January 2003, Viacom Inc., one of the world's largest media companies, in collaboration with the
Henry J. Kaiser Family Foundation, a leader in health information and research, launched KNOW
HIV/AIDS, an unprecedented, global media campaign to combat HIV/AIDS through public service
advertisements (PSAs), television and radio programming, and free print and online content. In October
2003, Viacom announced an expansion of this media campaign to Europe.
Kenneth Cole Productions, the $1 billion shoe and accessories company, began in 1996 to donate
advertising space for creative HIV/AIDS awareness campaigns. Starting with several hundred thousand
dollars of in-kind advertising donations, this U.S. corporation has consistently demonstrated its courage,
idealism, and caring through the years, and now donates more than $2 million in ad placements every
year.
This past year, the M.A.C. AIDS Fund, in partnership with the Elton John AIDS Foundation, donated its
resources and staff to a series of Public Service Announcements (PSAs), all ending with the warning
“AIDS Ain’t Over”. M.A.C. AIDS Fund spokespeople and affiliated celebrities introduce each PSA, and
are joined by every-day youth, to frankly raise their voices on issues related to HIV/AIDS and safer sex.
• The corporate sector also contributed to HIV/AIDS through essential workplace
programs, which are also consistent with growing trends in the corporate social
responsibility/corporate citizenship arena generally.  Companies, particularly those with
large workforces in heavily affected regions, committed resources to fight HIV/AIDS in
the workplace through comprehensive programs including non-discriminatory policies,
awareness and prevention (including distribution of condoms), and – very importantly –
access to care, support and treatment.
Selected Companies with Efforts to Address HIV/AIDS in the Workplace29
Anglo American plc Heineken NV
Anglo Gold Home Depot
BMW International Business Machines (IBM)
British American Tobacco Nestlé
British Petroleum Old Mutual
Chevron Texaco Royal Dutch / Shell Group of Companies
Coca-Cola Company Standard Chartered Bank
DaimlerChrysler AG Unilever plc
Ford Motor Company Whirlpool
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INTERNATIONALU.S. Grantmakers Making International HIV/AIDS Grants
• U.S.-based HIV/AIDS grantmakers reported HIV/AIDS grantmaking in 2001 and 2002
with a focus on both U.S. and international HIV/AIDS.30
• The past few years have witnessed a significant increase in attention to the global
HIV/AIDS issue by U.S.-based grantmakers, which mirrors the growing focus on
international HIV/AIDS by the media, the U.S. government and others.
• The largest U.S.-based HIV/AIDS grantmakers tended to focus HIV/AIDS grantmaking on
the international HIV/AIDS pandemic, while smaller U.S. grantmakers tended to focus
most of their HIV/AIDS grantmaking on the HIV/AIDS pandemic in the U.S.










Top 10 U.S. HIV/AIDS Grantmakers 37% 63%
Next 15 HIV/AIDS Grantmakers 52% 48%
Next 25 HIV/AIDS Grantmakers 78% 22%


































































































BACKGROUND Background and Methods
Data collection process
FCAA collected the information for this report through the following steps:
• Compilation of a list of more than 150 potentially significant U.S.-based HIV/AIDS grantmakers.
• Review of the websites and annual reports of these U.S. grantmakers and interviews with a number of experts to
prioritize the list and to select 78 U.S. grantmakers that had significant levels of recent HIV/AIDS grantmaking
and/or targeted HIV/AIDS as a priority funding issue.
• Distribution of a survey in July 2003 to these 78 grantmakers to request specific information about their
HIV/AIDS-related funding allocations in 2001 and 2002.
• Additional research and collection of HIV/AIDS grantmaking data from the Foundation Center and other sources -
where information was not available directly from grantmakers, to collect data on an unduplicated total set of 407
grantmakers.
• Comparison of data collected by FCAA surveys and other research methods with Foundation Center statistics for
2001 and 2002, and review of all numbers, significant trends, and notable dataset outliers.
• Compilation of final data on the 407 U.S. grantmakers into the text, tables and statistics for this report.
Who was surveyed and who responded
This report covers HIV/AIDS grant commitments from all sectors of U.S. philanthropy, including private foundations, family
foundations, community foundations, corporate grantmaking programs (corporate foundations and direct giving programs),
and major HIV/AIDS grantmaking charities in the U.S.  This report includes HIV/AIDS grants from the non-U.S. offices of
international foundations such as the Ford Foundation, the United Nations Foundation, and the Open Society Institute /
Soros Foundations network.  This report does not cover the efforts of many grantmakers working entirely outside the U.S.,
although FCAA acknowledges the emerging importance of HIV/AIDS grantmaking by foundations and other grantmaking
institutions based in Europe, Asia, Africa and Latin America.
In total, FCAA directly surveyed 78 grantmakers.  The researched grantmakers included all of the major U.S. HIV/AIDS
grantmakers known to FCAA, including those cited by FCAA to be the top 25 U.S. HIV/AIDS grantmakers for 2000 in our
2002 Report on AIDS Grantmaking by U.S. Philanthropy and the Foundation Center’s list of top 50 U.S. HIV/AIDS
grantmakers in 2000 and 2001.  FCAA received survey responses directly from 52 grantmakers  (67% of all foundations
researched).  Approximately ten grantmakers declined to answer the FCAA survey.  Thirteen grantmakers did not respond.
To supplement our information, FCAA used Foundation Center grants information for 355 additional grantmakers,
collected from the Foundation Center Foundation Directory Online in October 2003.  Thus, FCAA ended up with a data
set with specific HIV/AIDS grant commitment information for an unduplicated set of 407 grantmakers in 2001 and 2002,
including 3755 grants from 357 grantmakers in 2001 and 3652 grants from 167 grantmakers in 2002.
Definition of HIV/AIDS grantmaking
FCAA asked grantmakers to provide information about “the total dollar amount of your HIV/AIDS grantmaking
commitment in 2001 and 2002.”  FCAA is well aware of the complex categorization and accounting faced by grantmakers
who do funding in HIV/AIDS and other areas of health and human development.  Therefore we asked specifically about
‘external HIV/AIDS grantmaking’ that could include ‘grants made in other health, social, economic, and political areas as
long as some significant aspect of the grant includes a focus on addressing HIV/AIDS’.  
Importantly, we asked grantmakers to account for all grants by the calendar year they were authorized, allocated or
committed, so that, for example, multiyear grants would be fully counted in the year that they were awarded.  This is
consistent with the data collection methods of the Foundation Center, the Funders Network on Population, Reproductive
Health and Rights, and several other affinity groups.
The 52 grantmakers who responded to FCAA provided us with numbers based on their assessment of what is, and is not,
HIV/AIDS-related grantmaking.  However, by and large, our analysis of these numbers showed that grantmakers followed
our instructions on how to define HIV/AIDS grantmaking in each year.
FCAA’s data might differ from other institutions’ statistics in several ways:
• Major funders of population and reproductive health, such as the David and Lucile Packard Foundation and the
William and Flora Hewlett Foundation, provided FCAA with an inclusive list of their grants that fit FCAA’s
definition of ‘significant aspect focused on addressing HIV/AIDS’.  FCAA was intentionally inclusive of these
grants.
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• FCAA was intentionally inclusive in its definition of HIV/AIDS grant commitments by including the HIV/AIDS
grantmaking activity of several large public charities, donor-advised funds, corporate grantmaking programs, and
operating foundations.
• As is common practice in philanthropy research, but not always common practice in researching and reporting on
other funding data, FCAA tracks and reports on grant commitments in each calendar year, rather than grant
spending. Thus, for example, multiyear grants are counted fully in the year when they are initially committed.
• FCAA counted grants of every size, rather than just grants of more than $10,000.
In our 2003 research, FCAA did not ask about or analyze the intended use, theme, or issue area of each grant, such as
intended beneficiary populations or activities to be conducted.   FCAA encourages readers to learn more about
grantmakers activities by visiting their websites, listed at the end of this report.
Calculations of in-kind and programmatic support
In response to FCAA questions about in-kind or programmatic aspects of grantmaker effort, eight grantmakers provided a
dollar value and 35 grantmakers listed ‘zero’ as a response.  In many cases, those grantmakers who wrote ‘zero’ or
provided no information did add a comment to say that they were unable to provide this information.  This included U.S.
corporate and foundation grantmakers with major media campaigns, workplace education and treatment efforts, and
HIV/AIDS product donation programs. For example, the Henry J. Kaiser Family Foundation does a significant amount of
HIV/AIDS policy and public education work in the U.S., South Africa, and elsewhere.  Because this work is integrated into
other Foundation activities, such as webcasts and daily issue-specific news reports, it cannot easily be separately quantified
or valued.
Among the eight grantmakers that responded to this question, some listed internal expenditure for the program staff
administering the HIV/AIDS grants, and others listed non-grant resources such as grantmaker-administered programs, costs
of media and conferences and product donations.
Calculations of re-granting
The field of HIV/AIDS grantmaking includes an array of collaborations.  FCAA strongly encourages program and funding
collaborations, since they allow grantmakers to combine expertise and funding, reduce duplication and conflicting
priorities in grantmaking, and potentially increase both impact and sustainability of HIV/AIDS initiatives.  For this report,
where collaborations involve funding from one U.S. grantmaker to another, FCAA has tried to avoid double-counting.
Most importantly, FCAA included several large public charities and donor-advised funds in this report’s statistics.  These
charities include American Jewish World Service (AJWS), American Foundation for AIDS Research (amfAR), Broadway
Cares / Equity Fights AIDS (BC/EFA), Design Industries Foundation Fighting AIDS (DIFFA), Elizabeth Glaser Pediatric AIDS
Foundation (EGPAF), Tides Foundation, and the National AIDS Fund.  These seven charities re-granted between $6 million
and $10 million in funds from other major foundations, such as from the Bill & Melinda Gates Foundation, the Elton John
AIDS Foundation, and the Ford Foundation.  For example, in 2000, the Bill & Melinda Gates Foundation reported
awarding a three-year $15 million grant to the Elizabeth Glaser Pediatric AIDS Foundation, which in turn reported much of
this as HIV/AIDS grants to perinatal HIV prevention sites throughout the world.
For each institution listed in this report, FCAA has used each institution’s reported amounts of HIV/AIDS grant
commitments.  However, in reporting total HIV/AIDS grant commitments from all U.S. grantmakers for each year, FCAA
has accounted for and correspondingly subtracted for re-granting from among all 407 grantmakers.  This represents a
downward adjustment of $10 million in 2001 and $6 million in 2002.  This was approximately 2% of the total estimated
HIV/AIDS grant commitments for each year.
Aside from re-granting, FCAA estimates that these seven described charities raised and contributed substantial additional
funds to HIV/AIDS grantmaking – a total of approximately $17 million in 2001 and more than $20 million in 2002.  Some
of this amount came from U.S. government sources, such as the U.S. Agency for International Development (USAID), but
most was raised from individual donors and small foundations not otherwise included in FCAA statistics here.
Calculations of other HIV/AIDS funding efforts
As the global HIV/AIDS epidemic worsens, there has been an increasing charitable grantmaking response from
individuals, faith-based organizations, governments, and international institutions.  FCAA does not track these efforts,
but is working in partnership with other organizations to support a broad coalition effort at mapping the full multi-
sectoral response to HIV/AIDS.  These partners include UNAIDS, World Bank, the Henry J. Kaiser Family Foundation,
Global Business Coalition on HIV/AIDS, and the European HIV/AIDS Funders Network.
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END NOTES End Notes
                                                 
1 This report reflects information collected by FCAA directly from HIV/AIDS grantmakers and from the
Foundation Center about HIV/AIDS funding commitments in 2001 and 2002.
2  The term ‘HIV/AIDS grantmaking’ is used to describe all grantmaking related to HIV/AIDS as described
in the methodology section of this report. HIV/AIDS grantmaking overlaps with many other funding areas
in philanthropy, including reproductive and sexual health and rights, population, human rights,
biomedical research, economic development, international development, and funding directed to specific
populations, including women, adolescents, gays and lesbians, and ethnic and racial identity groups.
FCAA encourages readers to consult the Foundation Center’s Foundation Giving Trends 2003 and other
publications to compare HIV/AIDS grantmaking with these other interest areas.
3  In this report, the term ‘grantmaker’ is used to encompass private foundations, corporate giving
programs, and selected public charities that make grants related to HIV/AIDS.  Further information on
many of these grantmakers can be found online at the Foundation Center at Foundation Directory Online
at www.fconline.fdncenter.org.
4  As is common practice in philanthropy research, FCAA tracks and reports on grant commitments in
each calendar year, rather than grant spending in a given year. Thus, for example, multiyear grants are
counted fully in the year when they are initially committed. This means that aggregate data on HIV/AIDS
grantmaking commitments will be different than data on HIV/AIDS spending, even from the same
institution. Readers are therefore cautioned when comparing the FCAA data in this report, based on a
commitment analysis, versus other data on HIV/AIDS philanthropy for the same years, which may be
based on a spending analysis.
5  FCAA. Report on AIDS Grantmaking by U.S. Philanthropy.  June 2002.  At www.fcaaids.org
6  FCAA.  HIV/AIDS Philanthropy: History and Current Parameters 1981-2000.  January 2003. At
www.fcaaids.org
7  UNAIDS.  AIDS Epidemic Update.  December 2002.  Several central sources for current global statistics
about HIV/AIDS include the Centers for Disease Control and Prevention (CDC) (www.cdc.gov), the Henry
J. Kaiser Family Foundation  (www.kff.org), and UNAIDS (www.unaids.org).
8  Alagari P, Summers T, Kates, J.  Federal HIV/AIDS Spending: A Budget Chartbook - Fiscal Year 2002.
Henry J. Kaiser Family Foundation. September 2003.  At www.kff.org/content/2003/6076/6076v2.pdf
9  Alagiri P, Summers T, Kates J. Trends in U.S. Spending on HIV/AIDS. Henry J. Kaiser Family Foundation.
July 2002.  At www.kff.org
10  National Organizations Responding to AIDS (NORA).  Fiscal Year 2003 HIV/AIDS Appropriations
Recommendations.  May 2003.
11  The National Alliance of State and Territorial AIDS Directors (NASTAD).  NASTAD 2003 Policy
Priorities.  June 2003.  At
www.nastad.org/documents/public/PublicPolicy/200364NASTAD2003PolicyPriorities.pdf
12  UNAIDS.  Report on the State of HIV/AIDS Financing: Programme Coordinating Board, 14th Meeting.
UNAIDS/PCB(14)/03 Conference Paper 2a  25 June 2003.  At www.unaids.org
13  UNAIDS.  Fact sheet: Meeting the need.  June 2003.  At www.unaids.org/fact_sheets
14  Joint United Nations Programme on HIV/AIDS (UNAIDS).  Press release: Implementing the Declaration
of Commitment on HIV/AIDS.  22 September 2003.  At www.unaids.org/html/pub/Media/Press-
Releases01/UNGASS_Pressrelease_2003_en_doc.htm
15  UNAIDS.  Report: Accelerating Action Against AIDS in Africa.  Released at the International
Conference on AIDS and STIs in Africa (ICASA), Nairobi, 21 September 2003. At www.unaids.org
16  For example, see the brief discussion of the issues in developing a consistent methodology of resource
gap analysis in HIV/AIDS in the June 2003 UNAIDS PCB Report on HIV/AIDS financing, cited above.
17 The total HIV/AIDS funding commitment for 2001 is derived from direct reporting from 52 grantmakers
and indirect reporting to the Foundation Center by 305 additional grantmakers as described in the
methods section of this report (on page 14).  The total for 2001 is adjusted downward by $10 million to
account for re-granting.
18  FCAA. Report on AIDS Grantmaking by U.S. Philanthropy.  June 2002.  At www.fcaaids.org
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19  Historically, FCAA has used independent research, direct contact with grantmakers, and specialized
experience in the field of HIV/AIDS grantmaking to complement data from The Foundation Center. Unlike
the Foundation Center, FCAA statistics include grants of less than $10,000 and include grants of several
major HIV/AIDS public charities, such as American Jewish World Service (AJWS), American Foundation
for AIDS Research (amfAR), Broadway Cares / Equity Fights AIDS (BC/EFA), Design Industry Foundation
Fighting AIDS (DIFFA), Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Tides Foundation, and the
National AIDS Fund.
20 The total HIV/AIDS funding commitment for 2002 is derived from direct reporting from 52 grantmakers
and indirect reporting to the Foundation Center by 115 additional grantmakers as described in the
methods section of this report (on page 14).  The total for 2002 is adjusted downward by $6 million to
account for re-granting.
21 This is potentially a 42% decrease from 2001 to 2002. Data for 2002 is still incomplete, with only 167
of 407 U.S. grantmakers having reported grants for 2002.  However, this 2002 data does include most of
the largest HIV/AIDS grantmakers and therefore, given the distribution of HIV/AIDS grantmaking, includes
most of the HIV/AIDS grantmaking amounts for the year.
22  According to Highlights of the Foundation Center’s Foundation Yearbook, 2003 edition, overall
foundation giving in 2002 held steady at an estimated $30.3 billion, almost unchanged from $30.5 billion
in 2001. At http://fdncenter.org/research/trends_analysis/index.html
23  From 2001 to 2002, ten U.S. grantmakers increased their HIV/AIDS grantmaking commitments by
more than $1 million.  These ten grantmakers were The Rockefeller Foundation, The United Nations
Foundation, The Robert Wood Johnson Foundation, The W.K. Kellogg Foundation, The Doris Duke
Charitable Foundation, The M.A.C. AIDS Fund, The Elizabeth Glaser Pediatric AIDS Foundation, The
Bristol-Myers Squibb Foundation, The Open Society Institute / Soros Foundations Network, and The Tides
Foundation.
24 Funding payout levels from the Bill & Melinda Gates Foundation were derived by calculating the
annual payout for each grant made in 2000, 2001, and 2002, assuming a steady payout rate for all
multiyear grants.
25  FCAA defines ‘regionally-focused grantmakers’ as those grantmakers with significant geographic
interest or limitations to a U.S. city, metropolitan area, state, or region.
26 Information about private-sector HIV/AIDS grantmaking and other efforts can also be found at the web
site of the CDC Business Responds to AIDS / Labor Responds to AIDS at www.hivatwork.org and at the
web site of the Global Business Coalition on HIV/AIDS at www.businessfightsaids.org.
27 According to the National Committee for Responsive Philanthropy, an estimated 50% of corporate
philanthropy is undisclosed to the American public.  National Committee for Responsive Philanthropy.
The NCRP Quarterly, Summer 2003. p 7.
28 For more information, readers are also encouraged to read the latest FCAA AIDS Is Your Business
corporate update report, published in September 2003 and available at www.fcaaids.org
29 From the web site of the Global Business Coalition on HIV/AIDS, September 2003, selecting companies
with a substantial U.S. presence and with workforces of more than 1000 employees.  At
www.businessfightsaids.org
30 To try to maximize international funding and expertise, U.S. grantmakers making international grants
often work with non-governmental organizations (NGOs) and multilateral agencies, such as United
Nations agencies or the Global Fund to Fight AIDS, Tuberculosis, and Malaria. In some cases, these
partners will re-grant funds using their specialized knowledge of health and funding in a particular region.
More information about international NGOs can be found in the annual Global Health Council directory
of international NGOs at www.globalhealth.org.  More information about the Global Fund can be found
at www.globalfundatm.org
31 In past reports on overall HIV/AIDS grantmaking, FCAA was unable to collect precise data on
distinctions and percentages of domestic versus international grants by U.S.-based funders. Thus,
assessment of any trends in this area is difficult to make.
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WEB SITES
2001 and 2002 Top 50 U.S. HIV/AIDS Grantmaker Web Sites
Abbott Laboratories Fund (IL) www.abbott.com
Abell Foundation, The (MD) www.abell.org
Altria Group, Inc. (NY) www.altria.com
American Jewish World Service (NY) www.ajws.org
amfAR (NY) www.amfar.org
Association François-Xavier Bagnoud (MA) www.fxb.org
AT&T Foundation (NY) www.att.com/foundation
Atlantic Philanthropies, The (NY) www.atlanticphilanthropies.org
Bristol-Myers Squibb Foundation (NY) www.bms.com
Broadway Cares/Equity Fights AIDS (NY) www.bcefa.org
Burroughs Wellcome Fund (NC) www.bwfund.org
Cafritz Foundation, The Morris & Gwendolyn (DC) www.cafritzfoundation.org
California Endowment, The (CA) www.calendow.org
California Wellness Foundation, The (CA) www.tcwf.org
Carnegie Corporation of New York (NY) www.carnegie.org
Comer Foundation, The (IL) www.comer-foundation.org
Dade Community Foundation (FL) www.dadecommunityfoundation.org
Irene Diamond Fund (NY) No website
DIFFA (NY) www.diffa.org
Donner Foundation, Inc., The William H. (NY) www.donner.org
Doris Duke Charitable Foundation (NY) www.ddcf.org
Duke Endowment, The (NC) www.dukeendowment.org
Firelight Foundation, The (CA) www.firelightfoundation.org
Ford Foundation (NY) www.fordfound.org
Gates Foundation, Bill & Melinda (WA) www.gatesfoundation.org
Gill Foundation (CO) www.gillfoundation.org
Elizabeth Glaser Pediatric AIDS Foundation (DC) www.pedaids.org
Hewlett Foundation, The William and Flora (CA) www.hewlett.org
Houston Endowment Inc. (TX) www.houstonendowment.org
International Fund for Health & Family Planning (NY) No website
Elton John AIDS Foundation (CA) www.ejaf.org
Robert Wood Johnson Foundation, The (NJ) www.rjwf.org
Kaiser Family Foundation, The Henry J. (CA) www.kff.org
Kellogg Foundation, W.K. (MI) www.wkkf.org
Levi Strauss Foundation www.levistrauss.com/responsibility/foundation
M⋅A⋅C AIDS Fund (NY) www.macaidsfund.org
MacArthur Foundation, The John D. and Catherine T. (IL) www.macfound.org
McCormick Tribune Foundation, Robert R. (IL) www.rrmtf.org
Meadows Foundation, Inc., The (TX) www.mfi.org
Merck Company Foundation, The (NJ) www.merck.com
Meyer Foundation (DC) www.meyerfoundation.org
Mott Foundation, Charles Stewart (MI) www.mott.org
National AIDS Fund (DC) www.aidsfund.org
New York Community Trust, The (NY) www.nyct-cfi.org
Open Society Institute / Soros Foundations Network (NY) www.soros.org
20
WEB SITES
2001 and 2002 Top 50 U.S. HIV/AIDS Grantmaker Web Sites
Overbrook Foundation, The (NY) www.overbrook.org
Packard Foundation, The David and Lucile (CA) www.packfound.org
Pew Charitable Trusts, The (PA) www.pewtrusts.com
Pfizer Foundation, The (NY) www.pfizer.com
Prudential Foundation, The (NJ) www.prudential.com
Public Welfare Foundation (DC) www.publicwelfare.org
Robin Hood Foundation (NY) www.robinhood.org
Rockefeller Brothers Fund (NY) www.rbf.org
Rockefeller Foundation, The (NY) www.rockfound.org
San Francisco Foundation, The (CA) www.sff.org
Starr Foundation, The (NY) www.fdncenter.org/grantmaker/starr/
Tides Foundation (CA) www.tides.org
Tisch Foundation Inc. (NY) No website
United Nations Foundation (DC) www.unfoundation.org
Henry van Ameringen Foundation (NY) No website
Wells Fargo Foundation (CA) www.wellsfargo.com
ABOUT FCAA About FCAA
Organized in 1987, Funders Concerned About AIDS is an officially recognized philanthropic affinity group
whose mission is to mobilize philanthropic leadership and resources, domestically and internationally, to
eradicate the HIV/AIDS pandemic and to address its social and economic consequences.
As a strong collective of local, national and international grantmakers, FCAA fully appreciates the
destructiveness of the HIV/AIDS pandemic, including the insidious impact it increasingly has on a wide
range of initiatives, causes and communities that philanthropy has supported for decades. FCAA's work
assumes that only a coordinated, multi-sector response, which includes significant philanthropic support and
leadership, can address these challenges comprehensively.
Thus, in order to sustain effective programs against HIV/AIDS and successfully leverage the creation of new
approaches and initiatives in the United States and globally, FCAA exercises its leadership to:
• Increase philanthropic resources dedicated to combating HIV/AIDS;
• Enhance the number and diversity of grantmakers involved in HIV/AIDS; and
• Facilitate the most efficient, collaborative and strategic expenditure of HIV/AIDS grants in ways that both
address and transcend divisions of geography, race, economic status, sexual orientation, gender,
religion, age, disability and drug use.
FCAA offers extensive programming to its grantmaker network and also works in collaboration with public
policymakers, AIDS organizations and others to carry out its mission.  For a fuller description of FCAA's many
products, services and collaborations, visit the website: www.fcaaids.org.
FCAA Board of Directors
Beth Darmstadter*
















Levi Strauss & Co.
Irene Crowe






Ms. Foundation for Women
Jennifer Kates*
The Henry J. Kaiser Family Foundation
Cindy T. Rizzo
The Boston Foundation
Gary Schwartz
Tides Foundation
Sue Simon
Open Society Institute
Sarah Williams
The Pfizer Foundation
*Executive Committee Member
